Description
Belumosudil
Each film-coated tablet contains Belumosudil mesylate 242.5mg equivalent to Belumosudil … 200mg.
INDICATION
LuciBelu is a kinase inhibitor indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft- versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
DOSAGE AND USE
Recommended Dosage: 200 mg taken orally once daily with food.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD. No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of reach of Children. Do not administer LuciBelu during Pregnancy and Lactation.
Reviews
There are no reviews yet.